• Today April 22
January 10, 2024 11:50
LTIMindtree Launches Hybrid Cloud Management Platform; Canvas CloudXperienz
LTIMindtree (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ltimindtree.com%2F&esheet=53879323&newsitemid=20240108584411&lan=en-US&anchor=LTIMindtree&index=1&md5=5afa214dbd79736
January 10, 2024 11:45
VeriSilicon’s 2nd generation automotive ISP series IP passed ISO 26262 ASIL B and ASIL D certifications
VeriSilicon (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.verisilicon.com%2Fen%2FHome&esheet=53878580&newsitemid=20240108143511&lan=en-US&anchor=VeriSilicon&index=1&md5=1b9a6f
January 10, 2024 11:10
VeriSilicon Unveils the New VC9800 IP for Next Generation Data Centers
VeriSilicon (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.verisilicon.com%2Fen%2FHome&esheet=53878552&newsitemid=20240108169595&lan=en-US&anchor=VeriSilicon&index=1&md5=ddbe36
Adel District ( Photo: Adel Real Estate)
January 10, 2024 10:15
Adel Real Estate Unveils Blueprints of Adel District, the Largest Urban Development Project in Dammam, Saudi Arabia
Adel Real Estate (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fadelrealestate.com.sa%2Fhome-en%2F&esheet=53878588&newsitemid=20240108289909&lan=en-US&anchor=Adel+Real+Estate&index
January 10, 2024 10:10
Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces that it has entered into
January 09, 2024 16:50
Faraday Collaborates in Arm Total Design to Provide Arm Neoverse CSS-based Design Services
Faraday Technology Corporation (TWSE: 3035), a leader in ASIC design services and IP solutions, announces its participation as a design service partner in Arm® Total Design, underscoring the importanc
(Photo: Business Wire)
January 09, 2024 15:15
ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome
ENYO Pharma (“ENYO”) announced that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2 clinical study of
January 09, 2024 14:00
Validant Group of Companies Unite as ELIQUENT Life Sciences
The Validant Group of companies today announced a strategic repositioning that unites the five companies as one global regulatory brand: ELIQUENT Life Sciences. ELIQUENT Life Sciences is the fusion
dSPACE is expanding its partnership with the IAC and will support university racing teams not only w
January 09, 2024 11:10
Partnership with the Indy Autonomous Challenge (IAC) Expanded: dSPACE Supports University Autonomous Racing Teams as Exclusive Software-in-the-Loop Technology Sponsor
dSPACE, one of the world’s leading providers of simulation and validation solutions, is expanding its partnership with the Indy Autonomous Challenge (IAC) and will support its university racing teams
January 09, 2024 09:30
ExaGrid’s FY 2023 Results—A Record-Breaking Year for Company
ExaGrid® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.exagrid.com%2F&esheet=53878160&newsitemid=20240108089855&lan=en-US&anchor=ExaGrid&index=1&md5=7de7ae060c395b71465973c8cf
Morgan Stanley Expansion Capital Leads $34M Series C Investment in Vortexa (Graphic: Business Wire)
January 09, 2024 08:56
Morgan Stanley Expansion Capital Leads $34M Series C Investment in Vortexa
Vortexa, the leading real-time global analytics platform for energy and freight markets, is excited to announce the successful completion of its $34 million Series C funding round. Investment funds ma
Belkin supercharges into CES 2024 with powerful new product lineup (Photo: Business Wire)
January 08, 2024 11:15
Belkin supercharges into CES 2024 with powerful new product lineup
Belkin (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.belkin.com%2Fus%2F&esheet=53878128&newsitemid=20240107725407&lan=en-US&anchor=Belkin&index=1&md5=4c3ab7b48644e77a2d26f3f0c
January 08, 2024 10:55
Denodo Concludes the Largest Worldwide DataFest Events Focusing on the Importance of Cloud, Generative AI, and Logical Data Management
Denodo (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.denodo.com%2Fen&esheet=53870296&newsitemid=20231213729266&lan=en-US&anchor=Denodo&index=1&md5=c04cc30f1aea450b28d8df9f6ee1
January 07, 2024 13:23
Quectel Issues Further Cease and Desist Notice to Competitors for Unfair and Deceptive Business Practices
Quectel Wireless Solutions, a global IoT solutions provider, today sent a cease-and-desist letter to Cavli Wireless of San Jose, CA, USA, demanding that it immediately stop making false accusations ab
Seasoned tech sales executive joins Boomi to spearhead global sales organization and fuel rapid grow
January 07, 2024 13:16
Boomi Appoints Matt Heinz as Chief Revenue Officer
Boomi™ (https://boomi.com/), the intelligent connectivity and automation leader, today announced the appointment of Matt Heinz as Chief Revenue Officer (CRO), responsible for leading Boomi’s growing g
HistoSonics Edison Histotripsy System (Photo: Business Wire)
January 07, 2024 12:54
World’s First Patients Treated With Novel Edison® Histotripsy System
HistoSonics, (www.histosonics.com), the manufacturer of the non-invasive Edison® Histotripsy System, announced today a patient from the University of Rochester Medical Center has received the world’s
Afiniti announces the appointment of Mike Myshrall as Chief Financial Officer. (Photo: Business Wire
January 07, 2024 12:45
Afiniti Appoints Mike Myshrall as Its CFO
Afiniti, a leading customer experience (CX) artificial intelligence (AI) applications and infrastructure provider, announces the appointment of Mike Myshrall as Chief Financial Officer. “I am delig
January 07, 2024 11:33
Quectel Responds to the Request by the House Select Committee on China to Consider Barring U.S. Investments in the Company
Quectel Wireless Solutions, a global IoT solutions provider, issued the below statement in response to the recent request made to the Biden administration by the Select Committee on China of the U.S.
January 07, 2024 11:23
Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the fourth quarter and full year ending December 31, 2023
The Projection Mapping Show (Photo: Business Wire)
January 07, 2024 11:18
New Year’s Eve Countdown Event “HAPPY NEW YEAR TOKYO” Was Held for the First Time at the Tokyo Metropolitan Government Building!
In order to see off 2023 and share the charms of Tokyo and a feeling of anticipation for 2024, the Tokyo Metropolitan Government held the “HAPPY NEW YEAR TOKYO” New Year’s Countdown Event at Tomin Hir
Poon choi is a popular dish in recent years, especially during the Chinese New Year time (Credit: Pa
January 05, 2024 14:33
Celebrate CNY in Hong Kong Like a Local: Experience Little-Known Festive Traditions and Not-to-Be-Missed Events
The Chinese New Year is always associated with a form of archaic or even a rather dull festival, rooted as it is in traditional Chinese customs. But that couldn’t be further from the truth - Hong Kong
Sourcefit Secures Strategic Investment from 9 Basil, NextGen Ventures, and Rocket Equities
January 05, 2024 11:35
Sourcefit Secures Strategic Investment from 9 Basil, NextGen Ventures, and Rocket Equities
Sourcefit (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsourcefit.com%2F&esheet=53874315&newsitemid=20231222601715&lan=en-US&anchor=Sourcefit&index=1&md5=a19b18389d10064dbedc72c9f
January 05, 2024 11:15
ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that Amit D. Munshi, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthca
January 05, 2024 10:50
India’s Apex Court Disposes Case Against Adani Group in Hindenburg Matter
India’s Supreme Court on Wednesday disposed-off the public interest litigations (PILs) filed last year after a short seller published a report making malicious and baseless claims against the Adani Gr
January 05, 2024 10:30
Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
Merck, a leading science and technology company, today announced a licensing agreement with Inspirna, Inc. (New York, NY) for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine tran
25 per page50 per page75 per page100 per page